Antibodies
These 10 antibodies recognize different epitopes of the SARS-CoV-2 Spike glycoprotein, nine of which are SARS-CoV-2-specific and do not cross-react with other human coronaviruses
| 2 min read
This standard 96-well ELISA based assay is a game changer for evaluating convalescent plasma, antibody therapies and determining the effectiveness of vaccines for COVID-19
| 2 min read
ImmunoRank offers a faster, simpler, more cost effective way to identify high titer convalescent plasma for use in both treating covid-19 patients and for creating covid-19 hyperimmune globulins
| 2 min read
This COVID-19 diagnostic tool will validate serological testing for antibodies, helping to fight against the disease
| 2 min read
Explore a new efficient alternative to clarify and sterilize mammalian cell cultures
| 1 min read
A new SARS-CoV-2 spike protein biosensor chip was successfully deployed for simultaneous measurements of IgG, IgA, and IgM using only 2 µl of serum per patient
| 2 min read
Until now, it was not clear how SARS-CoV-2-specific T cell responses relate to antibody responses or to the clinical course of COVID-19 in humans
| 2 min read
However, SARS-CoV-2 antibody serology assays developed by MD Anderson researchers accurately detect neutralizing antibodies
| 2 min read
Acquisition strengthens LGC’s existing product offering to the IVD sector
| 2 min read
Despite some anecdotal evidence, scientists still don't have high-quality data showing that the treatment actually works
| 2 min read
Chromatrap® ChIP kits deliver fast workflow, enabling users to process up to 96 ChIP assays simultaneously in just one day
| 2 min read
Evidence is mounting that SARS-CoV-2 uses heparan sulfates during the initial attachment to hosts cells, and this interaction appears to increase the affinity for the critical receptor, ACE
| 2 min read
